STAT3 and AL amyloidosis: As a multitarget kinase inhibitor, AT-9283 can inhibit the process of STAT3 tyrosine phosphorylation and inhibit multiple myeloma cell proliferation [37] and is widely used in cancer treatment [38, 39].